Clinical Trial

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study acronym: IVITOC
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a randomized controlled study evaluating safety and efficacy of repeated immunoadsorption versus immunoglobulins in steroid-refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-05-05; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2023-05-11
Trial Details
NCT Number NCT04881682
Lead Sponsor University of Ulm
Collaborators: Miltenyi Biomedicine GmbH
Conditions CIDP
Enrollment 20 participants
Start Date 2023-05-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01